Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Patients With Colchicine-Resistant or Colchicine-Intolerant Familial Mediterranean Fever | MicrobiomeTrials
Goflikicept for Resolution and Prevention of Attacks in Pediatric and Adolescent Patients With Colchicine-Resistant or Colchicine-Intolerant Familial Mediterranean Fever
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-12Est. Completion: 2029-05
Enrollment target: 18 participants
Locations
Federal State Budgetary Scientific Institution "V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia
State Budgetary Institution of Healthcare of the City of Moscow "Morozovskaya Children's City Clinical Hospital of the Moscow City Health Department" (GBUZ "Morozovskaya DGBK DZM"), Moscow, Russia
LLC "Medical Technologies", Saint Petersburg, Russia